Gorai I, Nakazawa T, Miyagi E, Hirahara F, Nagashima Y, Minaguchi H
Department of Obstetrics and Gynecology, Yokohama City University School of Medicine, Japan.
Gynecol Oncol. 1995 Apr;57(1):33-46. doi: 10.1006/gyno.1995.1097.
Two permanent human ovarian clear cell adenocarcinoma lines (OVISE and OVTOKO) were established from metastatic tumors of two patients who were treated with five to six courses of CAP chemotherapy. The two cell lines grow on monolayers and showed a variety in both size and shape: small or moderately sized cuboidal cells, columnar cells, spindle-shaped cells, and malignant tumor giant cells. The cell lines have been in culture for 4 to 6 years, the passage number varying from 160 to 220. The mean population-doubling time of the two cells was 60 to 70 hr. The OVISE cells shed tumor-associated antigens CA19-9, CA125, and TPA in the culture medium, whereas the OVTOKO cells did not secrete them at detectable levels. Immunohistochemical analysis showed that coexpression of cytokeratins and vimentin was preserved in the two cell lines, which is a feature of cultured epithelial origin. Cytokeratin polypeptides 7, 8, 18, and 19 were expressed in both cell lines. The EGF receptor was more intensely expressed in the OVTOKO cells than in the OVISE cells. The estrogen and progesterone receptors were negative in both cell lines. The two cell lines showed no chemosensitivity to anticancer drugs including cisplatin, doxorubicin, cyclophosphamide, and etoposide. Heterotransplantation of the two cell lines reflected the origin of cells. Intraperitoneal transplantation of the OVTOKO cells yielded peritoneal implantation and distant metastasis, whereas that of the OVISE cells showed no dissemination and metastasis. These new ovarian clear cell adenocarcinoma lines will provide a relevant experimental system for further investigations into the intrinsic alterations responsible for malignant progression and chemoresistance.
从两名接受了五到六个疗程CAP化疗的患者的转移性肿瘤中建立了两株人卵巢透明细胞腺癌永久细胞系(OVISE和OVTOKO)。这两株细胞系以单层形式生长,细胞大小和形状各异:有小的或中等大小的立方体细胞、柱状细胞、梭形细胞以及恶性肿瘤巨细胞。这些细胞系已培养4至6年,传代次数在160至220次之间。两株细胞的平均群体倍增时间为60至70小时。OVISE细胞在培养基中释放肿瘤相关抗原CA19 - 9、CA125和TPA,而OVTOKO细胞未分泌可检测水平的这些抗原。免疫组织化学分析表明,两株细胞系中细胞角蛋白和波形蛋白的共表达得以保留,这是培养的上皮来源细胞的一个特征。细胞角蛋白多肽7、8、18和19在两株细胞系中均有表达。表皮生长因子受体在OVTOKO细胞中的表达比在OVISE细胞中更强。两株细胞系中的雌激素和孕激素受体均为阴性。这两株细胞系对包括顺铂、阿霉素、环磷酰胺和依托泊苷在内的抗癌药物均无化学敏感性。两株细胞系的异种移植反映了细胞的起源。OVTOKO细胞腹腔内移植产生了腹膜种植和远处转移,而OVISE细胞腹腔内移植未出现播散和转移。这些新的卵巢透明细胞腺癌细胞系将为进一步研究导致恶性进展和化疗耐药的内在改变提供一个相关的实验系统。